We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Paramedical Consultation in Telemedicine

This study has been terminated.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01530789
First Posted: February 10, 2012
Last Update Posted: August 6, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète
  Purpose
Feasibility monocentrique opened study estimating the use of an electronic personalized educational plan (ePEP) for the follow-up by nurses of 50 patients diabetics type 1 during 6 months having an electronic pad.

Condition
Type 1 Diabetic

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Evaluation of Paramedical Consultation in Type 1 Diabetic Patients in Telemedicine

Further study details as provided by Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète:

Primary Outcome Measures:
  • Percentage of patient using the system [ Time Frame: 6 month ]
    The using of the system is estimated by the frequency of dose proposition by electronic pad


Secondary Outcome Measures:
  • satisfaction level of the patient and quality of life [ Time Frame: 6 month ]
  • satisfaction level of physician [ Time Frame: 6 month ]
    The satisfaction level of physician about the follow-up by e-PEP

  • satisfaction level of the telemedecin nurse [ Time Frame: 6 month ]
    Evaluation of the satisfaction level of the telemedecin nurse about the follow-up by e-PEP


Enrollment: 50
Study Start Date: May 2011
Study Completion Date: April 2014
Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   12 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Diabetic type 1 patients with the electronic pad
Criteria

Inclusion Criteria:

  • patient diabetic type 1
  • patient with the electronic pad in a smartphone
  • adults
  • children between 12 and 17 years 11 months
  • patient having signed the consent

Exclusion Criteria:

  • patient diabetic type 2
  • patient without the electronic pad in a smartphone
  • children below 12 years old
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète
ClinicalTrials.gov Identifier: NCT01530789     History of Changes
Other Study ID Numbers: 2011-A00311-40
First Submitted: February 8, 2012
First Posted: February 10, 2012
Last Update Posted: August 6, 2015
Last Verified: October 2012

Keywords provided by Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète:
Telemedecine
Telemedecine nurse
Delegation of tasks
Type 1 diabetes